The key incident monitoring and management system - history and role in quality improvement

被引:20
作者
Badrick, Tony [1 ]
Gay, Stephanie [1 ]
Mackay, Mark [1 ]
Sikaris, Ken [2 ]
机构
[1] RCPAQAP, Sydney, NSW, Australia
[2] Melbourne Pathol, Melbourne, Vic, Australia
关键词
Failure Mode Effects Analysis (FMEA); post-analytical error; pre-analytical error; Quality Indicators; LABORATORY MEDICINE; CLINICAL LABORATORIES; INDICATORS; EXPERIENCE; PROGRAM; PHASE;
D O I
10.1515/cclm-2017-0219
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The determination of reliable, practical Quality Indicators (QIs) from presentation of the patient with a pathology request form through to the clinician receiving the report (the Total Testing Process or TTP) is a key step in identifying areas where improvement is necessary in laboratories. Methods: The Australasian QIs programme Key Incident Monitoring and Management System (KIMMS) began in 2008. It records incidents (process defects) and episodes (occasions at which incidents may occur) to calculate incident rates. KIMMS also uses the Failure Mode Effects Analysis (FMEA) to assign quantified risk to each incident type. The system defines risk as incident frequency multiplied by both a harm rating (on a 1-10 scale) and detection difficulty score (also a 1-10 scale). Results: Between 2008 and 2016, laboratories participating rose from 22 to 69. Episodes rose from 13.2 to 43.4 million; incidents rose from 114,082 to 756,432. We attribute the rise in incident rate from 0.86% to 1.75% to increased monitoring. Haemolysis shows the highest incidence (22.6% of total incidents) and the highest risk (26.68% of total risk). "Sample is suspected to be from the wrong patient" has the second lowest frequency, but receives the highest harm rating (10/10) and detection difficulty score (10/10), so it is calculated to be the 8th highest risk (2.92%). Similarly, retracted (incorrect) reports QI has the 10th highest frequency (3.9%) but the harm/difficulty calculation confers the second highest risk (11.17%). Conclusions: TTP incident rates are generally low (less than 2% of observed episodes), however, incident risks, their frequencies multiplied by both ratings of harm and discovery difficulty scores, concentrate improvement attention and resources on the monitored incident types most important to manage.
引用
收藏
页码:264 / 272
页数:9
相关论文
共 17 条
  • [1] Quality indicators and specifications for key processes in clinical laboratories:: a preliminary experience
    Alsina Kirchner, Ma Jesus
    Alvarez Funes, Virtudes
    Biosca Adzet, Carme
    Domenech Clar, Ma Vicenta
    Ibarz Escuer, Merce
    Minchinela Girona, Joana
    Pastor Barellas, Rosa Ma
    Perich Alsina, Carmen
    Ricos Aguila, Carmen
    Trujillo Isern, Gloria
    Vilanova Navarro, Conrad
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (05) : 672 - 677
  • [2] [Anonymous], IMPR DIAGN HEALTHC
  • [3] Selecting clinical quality indicators for laboratory medicine
    Barth, Julian H.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 257 - 261
  • [4] Clinical quality indicators in laboratory medicine
    Barth, Julian H.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 9 - 16
  • [5] The cost of poor blood specimen quality and errors in preanalytical processes
    Green, Sol F.
    [J]. CLINICAL BIOCHEMISTRY, 2013, 46 (13-14) : 1175 - 1179
  • [6] Institute for Health Improvement, RISK PRIOR NUMB
  • [7] Error rates in Australian chemical pathology laboratories
    Khoury, M
    Burnett, L
    Mackay, MA
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (03) : 128 - 130
  • [8] Kristensen GBB, 2014, BIOCHEM MEDICA, V24, P114, DOI 10.11613/BM.2014.013
  • [10] Seven Q-Tracks Monitors of Laboratory Quality Drive General Performance Improvement Experience From the College of American Pathologists Q-Tracks Program 1999-2011
    Meier, Frederick A.
    Souers, Rhona J.
    Howanitz, Peter J.
    Tworek, Joseph A.
    Perrotta, Peter L.
    Nakhleh, Raouf E.
    Karcher, Donald S.
    Bashleben, Christine
    Darcy, Teresa P.
    Schifman, Ron B.
    Jones, Bruce A.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (06) : 762 - 775